Is PGT-P cutting edge or should we cut it out?

PGT for polygenic risk scoring (PGT-P) is a novel screening strategy of embryos for polygenic conditions and traits. With several companies now offering PGT-P, the clinical utility and ethics of polygenic risk scoring are being hotly debated. Join us live from the ASRM Annual Meeting as we debate the role of PGT-P in modern REI practice. We will be joined by a team of clinical and scientific experts to unpack both sides of the argument and hopefully arrive at a consensus.

Eve Feinberg, MD
Pietro Bortoletto, MD

Marja Brolinson, MD
Nathan Treff, PhD, HCLD
Lee Shulman, MD
Ginny Ryan, MD

Quick Links

Learn More About ASRM

Thousands of doctors, nurses, and other professionals in the field of reproductive medicine are advancing their careers with the latest news, continuing education, discounts, and networking opportunities. 

Ready to Join?  |  Renew